Clearmind enrolls first AUD patients in CMND-100 clinical trial - CMND News | RalliesClearmind enrolls first AUD patients in CMND-100 clinical trial
C
CMND• First AUD patients enrolled in CMND-100 trial
- Clearmind Medicine enrolled the first Alcohol Use Disorder patients in its CMND-100 clinical trial.
- Results have not been presented; the study will generate future safety and early efficacy readouts.
- First dosing in AUD patients marks the initial test of CMND-100 in the target condition, following prior healthy-volunteer dosing.
- The trial aims to assess whether CMND-100 can be administered safely while showing early signs of reducing harmful alcohol use.
PAI
•
